Could cause temporary or reversible harm; serious harm is unlikely.
Superpotent Drug: Out of specification assay result was obtained during stability testing.
| Brand name | TESTOSTERONE |
| Generic name | TESTOSTERONE |
| Active ingredient(s) | TESTOSTERONE |
| Distributed by / for | Actavis Pharma, Inc., Parsippany, NJ 07054, USA, Sachet |
| NDC | 0591-3216-17 |
| Full product label | Testosterone Gel 1% (25mg testosterone/2.5g of gel) 2.5 g per unit dose, Rx Only, 30 unit-dose packets per box. Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, US 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA, Sachet NDC 0591-3216-17, Carton NDC 0591-3216-30 |
| Recalling firm | Teva Pharmaceuticals USA Inc |
| Distribution | Nationwide in the USA |
| Quantity | 12354 cartons |
| Recall initiated | 2022-06-29 |
| Report date | 2022-08-03 |
| Recall completed | 2024-03-15 |
| Recall number | D-1289-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Parsippany NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗